Codex DNA Codex DNA Partners With RNAimmune on mRNA Synthesis Technologies Biopharmaceutical firm RNAimmune will help develop and validate mRNA synthesis technologies under development at San Diego-based Codex DNA. Codex DNA Q3 Revenues Grow 75 Percent, Company Acquires Eton Bioscience In its first full quarter as a public company, Codex DNA saw its net loss more than double to $9.8 million on sharply higher expenses. People in the News: New Appointments at Sema4, NHGRI, Dante Labs, Ancestry, More Codex DNA Q2 Revenues Rise 76 Percent The revenue increase was related to new products and a rise in royalties and collaboration research program revenue, according to the firm. In Brief This Week: Sophia Genetics, Twist Bioscience, Dante Labs, MGI, Codex DNA, More News items for the week of July 26, 2021. Jun 23, 2021 Codex DNA Closes $122.7M IPO Mar 19, 2021 New Products Posted to GenomeWeb: Roche, Twist Bioscience, Codex DNA, More Breaking News GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy Metabolomic Study Links 13 Metabolites to Coronary Heart Disease Risk Among African Americans Illumina Wins $8M Jury Verdict in BGI Patent Infringement Suit, Loses Patent Caris Life Sciences Facing FTC Lawsuit After Resisting Subpoena in Illumina, Grail Antitrust Case Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests The Scan Panel Votes for COVID-19 Pill A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says. But Not Harm New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare. Effectiveness Drop Anticipated Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports. Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.